Naomi Travers, NP
Dermatology · Poway, CANPI 1639550833
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.1% of the total across 404 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 19.0% — the pattern of someone who eats at a lot of different presentations.
Across 404 payments — averaging $24.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$868
- Sun Pharmaceutical Industries Inc.$735
- LEO Pharma Inc.$688
- Incyte Corporation$686
- Amgen$636
- plus $4K from 22 others
Across 1 payment — averaging $250.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$250
What the payments were for
- Speaking & faculty fees$1021%
- Food & beverage$9,58996%
- Education$2853%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 90 | $1,895 |
| Johnson & Johnson | 39 | $868 |
| Sun Pharmaceutical Industries Inc. | 26 | $735 |
| LEO Pharma Inc. | 38 | $688 |
| Incyte Corporation | 23 | $686 |
| Amgen | 31 | $636 |
| Sanofi | 13 | $612 |
| Novartis | 31 | $506 |
| Janssen Scientific Affairs, LLC | 4 | $475 |
| Pfizer | 24 | $456 |
| UCB, Inc. | 15 | $365 |
| Galderma Laboratories, L.p. | 12 | $329 |
| Regeneron | 3 | $279 |
| E.r. Squibb & Sons, L.L.C. | 7 | $247 |
| Regeneron Healthcare Solutions, Inc. | 10 | $242 |
| Lilly USA, LLC | 9 | $193 |
| Arcutis Biotherapeutics, Inc. | 7 | $142 |
| Strata Skin Sciences, Inc. | 2 | $139 |
| EPI Health, LLC | 2 | $120 |
| Boehringer Ingelheim | 4 | $105 |
| Almirall LLC | 5 | $103 |
| Organon | 3 | $38 |
| Genentech USA, Inc. | 1 | $23 |
| Journey Medical Corporation | 1 | $23 |
| Botanix SB Inc | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Verrica Pharmaceuticals Inc. | 1 | $18 |
| VYNE Pharmaceuticals Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,977 in reported general payments places this provider in the 80th percentile of 1,875 dermatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 12 | $44,765 |
| Clobetasol Propionate | 54 | $2,760 |
| Fluorouracil | 42 | $2,639 |
| Doxycycline Monohydrate | 18 | $481 |
| Ketoconazole | 36 | $458 |
| Doxycycline Hyclate | 15 | $331 |
| Triamcinolone Acetonide | 32 | $263 |
| Mupirocin | 18 | $121 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Poway
- Paul YamauchiSanta Monica$2.9M
- Jennifer SoungSanta Ana$2.8M
- Robert GreenbergLivermore$2.6M
- Neal BhatiaSan Diego$2.5M
- April ArmstrongLos Angeles$2.3M
- Jeffrey CrowleyBakersfield$2.1M
- Jashin WuCorona$2M
- Raja SivamaniSacramento$1.9M
- Tien NguyenFountain Valley$1.2M
- Tina BhutaniSan Francisco$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.